QR Kod

Proton pump inhibitor use and pancreatic risk: evidence from the UK biobank participants and animal experiments

Introduction Proton pump inhibitors (PPIs) are widely prescribed for gastrointestinal disorders and are often used empirically in patients with pancreatic disease, yet their long-term impact on pancreatic health remains unclear. We evaluated whether regular PPI use is associated with risks of acute...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Xin Gao, Zouhua Xu, Qingxie Liu, Chenchen Yuan, Xiaowu Dong, Xiaolei Shi, Qingtian Zhu, Keyan Wu, Hongwei Xu, Jiajia Pan, Guotao Lu, Weiming Xiao, Shengfeng Wang, Yaodong Wang
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2025-10-01
Seri Bilgileri:Frontiers in Pharmacology
Konular:
proton pump inhibitors
pancreatic disease incidence
drug safety
prospective cohort
health sciences
Online Erişim:https://www.frontiersin.org/articles/10.3389/fphar.2025.1673200/full
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller